ClinicalTrials.gg
CompletedNCT02325154THANIRSUpdated Dec 27, 2024Results posted

Cerebral Oxygenation in Total Hip Arthroplasty Patients

An interventional study of Cerebral Oximeter in Cerebral Oxygen Desaturation and Post-operative Delirium, sponsored by Hospital for Special Surgery, New York. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-27.

Sponsored by Hospital for Special Surgery, New York · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

We plan to investigate the relationship between hypotensive epidural anesthesia for hip arthroplasty and cerebral oxygen saturation.

Read the detailed description

The relationship between cerebral oxygenation and blood pressure in patients undergoing hypotensive epidural anesthesia has not been completely elucidated. Previous publications have demonstrated a low incidence of post-op cognitive dysfunction in patients undergoing hypotensive epidural anesthesia for total hip replacement (1-3) and that cerebral blood flow velocity is preserved as measured by transcranial Doppler (4). An earlier investigation by Dr. Yadeau demonstrated infrequent cerebral oxygen desaturation in spontaneously breathing patients undergoing shoulder arthroscopy, even in the presence of hypotension (4), but did not investigate outcomes in the cognitive domain or have a control group of patients undergoing surgery with general anesthesia. There has only been one study looking at cerebral oxygenation and hip surgery, which was performed in elderly patients with fractures. It demonstrated that patients with low pre-op regional cerebral oxygen saturation (rSO2) had higher incidence of delirium (5) but many of those patients had surgery under general anesthesia. Given the costs associated with post-op delirium, cognitive dysfunction and stroke (6) and based on the fact that previous publications from this institution have demonstrated both a low incidence of cognitive dysfunction and preservation of cerebral blood flow velocity using this anesthetic technique, we hypothesized that cerebral oxygen desaturation will not occur in this population.

02

Conditions studied

  • Cerebral Oxygen Desaturation
  • Post-operative Delirium

Browse trials for

03

In context

Emergence Delirium

788 studies on the registry are indexed under Emergence Delirium; 250 are open to participants now.

This study's enrollment of 100 is below the median of 120 across 491 interventional studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 226 studies on the registry; 40 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 22 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 18-80 years old undergoing unilateral total hip arthroplasty
  • Hypotensive epidural anesthesia

Exclusion criteria

Exclusion Criteria:

  • Contraindication to controlled hypotension and/or neuraxial anesthesia.
  • Severe pulmonary hypertension or pre-op systolic blood pressure reading >150 mm Hg
  • Moderate to severe valvular stenosis.
  • History of stroke, dementia, or post-op delirium
  • Prior OSA diagnosis
  • History of benzodiazepine use (regular use for longer than 3 months)
  • Chronic renal or hepatic disease (renal failure, history of liver failure, cirrhosis)
  • History of alcoholism or heavy alcohol intake (defined as averaging more than 3 drinks per night; recovery is OK)
  • Parkinson's disease
  • Severe chronic pulmonary disease
  • Total anterior hip approach being used
  • Hip resurfacing procedure
  • Non-English Speaking*

    • Questionnaires being used to assess mental status are only validated in English.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    THA Patients

    Patients undergoing unilateral total hip arthroplasty

    Device: Cerebral Oximeter

Interventions

  • DeviceCerebral Oximeter

    Use of cerebral oximeter to monitor cerebral oxygenation for occurence of desaturation events.

    Also known as: oximeter

06

What researchers measure

Primary outcomes

  1. Oxygen Desaturation Incidences

    The number of participant's experiencing an intra-operative cerebral oxygen desaturation event. Measured in the number of patients, beginning with the time the patients' enters the operating room and up to 4 hours.

    Time frame: Intra-operation (when the patient enters the operating room, up to 4 hours)

Secondary outcomes

  1. Duration of Oxygen Desaturation

    Duration of cerebral oxygen desaturation

    Time frame: Intra-op ( during the time the patient is in the operating room, up to 4 hours)

  2. Presence of Post-operative Delirium

    The number of patients who have post-operative delirium, as determined by counting the patients who suffer from this condition. Although recorded at various time points, the total number of participants experiencing post-operative delirium was summed and reported.

    Time frame: Post-op Day 1, Post-op Day 2

  3. Patients With Cognitive Dysfunction

    The number of patients considered to experience cognitive dysfunction as identified by low scores on the mini-Cog. The Mini-Cog checks for the brain function (or the cognitive impairment) of the participant. The Mini-Cog does this by examining a patient's ability in two areas. This is done via a three-word recall test and the Clock Drawing Test. 1. Three-Word Recall 2. The Clock Drawing Test (CDT) There are five total points a person can score on the Mini-Cog: * Give one point for each word that was correctly remembered. (0-3 points) * Give two points for a correctly drawn clock, meaning the numbers are in roughly the correct locations and two hands are pointed to the 11 and the 2. The length of the hands does not matter. (0 or 2 points) If a patient scores less than three points, they are counted as experiencing cognitive dysfunction. Although collected across different time points, the total number of patients scoring less than 3 points were summed and reported.

    Time frame: Post-op Day 1, Post-op Day 2

07

Results

Posted Mar 1, 2023

Participant flow

Participant flow — Overall Study
MilestoneTHA Patients
Started100
Completed99
Not completed1
Withdrew: Physician decision1

Outcome measures

PrimaryOxygen Desaturation Incidences

The number of participant's experiencing an intra-operative cerebral oxygen desaturation event. Measured in the number of patients, beginning with the time the patients' enters the operating room and up to 4 hours.

Time frame:
Intra-operation (when the patient enters the operating room, up to 4 hours)
Reported as:
Count of participants · Participants
Oxygen Desaturation Incidences
ParticipantsTHA Patients
Oxygen Desaturation Incidences4
SecondaryDuration of Oxygen Desaturation

Duration of cerebral oxygen desaturation

Time frame:
Intra-op ( during the time the patient is in the operating room, up to 4 hours)
Reported as:
Median · seconds
Duration of Oxygen Desaturation
secondsTHA Patients
Duration of Oxygen Desaturation11 (5 to 120)
SecondaryPresence of Post-operative Delirium

The number of patients who have post-operative delirium, as determined by counting the patients who suffer from this condition. Although recorded at various time points, the total number of participants experiencing post-operative delirium was summed and reported.

Time frame:
Post-op Day 1, Post-op Day 2
Reported as:
Count of participants · Participants
Presence of Post-operative Delirium
ParticipantsTHA Patients
Presence of Post-operative Delirium0
SecondaryPatients With Cognitive Dysfunction

The number of patients considered to experience cognitive dysfunction as identified by low scores on the mini-Cog. The Mini-Cog checks for the brain function (or the cognitive impairment) of the participant. The Mini-Cog does this by examining a patient's ability in two areas. This is done via a three-word recall test and the Clock Drawing Test. 1. Three-Word Recall 2. The Clock Drawing Test (CDT) There are five total points a person can score on the Mini-Cog: * Give one point for each word that was correctly remembered. (0-3 points) * Give two points for a correctly drawn clock, meaning the numbers are in roughly the correct locations and two hands are pointed to the 11 and the 2. The length of the hands does not matter. (0 or 2 points) If a patient scores less than three points, they are counted as experiencing cognitive dysfunction. Although collected across different time points, the total number of patients scoring less than 3 points were summed and reported.

Time frame:
Post-op Day 1, Post-op Day 2
Reported as:
Count of participants · Participants
Patients With Cognitive Dysfunction
ParticipantsTHA Patients
Post-Operative Day 1 — Abnormal Clock Drawing From baseline3
Post-Operative Day 1 — Word Recall decrease From baseline4
Post-Operative Day 2 — Abnormal Clock Drawing From baseline3
Post-Operative Day 2 — Word Recall decrease From baseline3

Adverse events

Collected over up to 2 days following surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
THA Patients0/99 (0%)0/99 (0%)0/99 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)THA Patients
Mean60.6 ± 9.9
Sex: Female, Male
Sex: Female, Male(Participants)THA Patients
Female52
Male47
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)THA Patients
Race Categories — Black or African American4
Race Categories — White86
Race Categories — Unknown9
Body Mass Index
Body Mass Index(kg/m^2)THA Patients
Mean28.2 ± 5.4
08

Study locations

1 site
  • Hospital for Special Surgery
    New York, New York 10021, United States
09

References and documents

Publications

  • Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA. 1995 Jul 5;274(1):44-50. PubMed 7791257 ↗
  • Sharrock NE, Fischer G, Goss S, Flynn E, Go G, Sculco TP, Salvati EA. The early recovery of cognitive function after total-hip replacement under hypotensive epidural anesthesia. Reg Anesth Pain Med. 2005 Mar-Apr;30(2):123-7. doi: 10.1016/j.rapm.2004.12.005. PubMed 15765453 ↗
  • Rade MC, Yadeau JT, Ford C, Reid MC. Postoperative delirium in elderly patients after elective hip or knee arthroplasty performed under regional anesthesia. HSS J. 2011 Jul;7(2):151-6. doi: 10.1007/s11420-011-9195-2. Epub 2011 Feb 11. PubMed 22754416 ↗
  • Yadeau JT, Liu SS, Bang H, Shaw PM, Wilfred SE, Shetty T, Gordon M. Cerebral oximetry desaturation during shoulder surgery performed in a sitting position under regional anesthesia. Can J Anaesth. 2011 Nov;58(11):986-92. doi: 10.1007/s12630-011-9574-7. Epub 2011 Aug 25. PubMed 21866430 ↗
  • Papadopoulos G, Karanikolas M, Liarmakopoulou A, Papathanakos G, Korre M, Beris A. Cerebral oximetry and cognitive dysfunction in elderly patients undergoing surgery for hip fractures: a prospective observational study. Open Orthop J. 2012;6:400-5. doi: 10.2174/1874325001206010400. Epub 2012 Sep 3. PubMed 22962570 ↗
  • McDaniel M, Brudney C. Postoperative delirium: etiology and management. Curr Opin Crit Care. 2012 Aug;18(4):372-6. doi: 10.1097/MCC.0b013e3283557211. PubMed 22732435 ↗
  • Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, Vaughn J, Nisman M. Cerebral oxygen desaturation events assessed by near-infrared spectroscopy during shoulder arthroscopy in the beach chair and lateral decubitus positions. Anesth Analg. 2010 Aug;111(2):496-505. doi: 10.1213/ANE.0b013e3181e33bd9. Epub 2010 May 27. PubMed 20508134 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2014, a primary completion of Aug 2016 and a completion of Aug 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Mar 2023, 6 years 7 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2014
First posted
Dec 24, 2014
Start
Dec 2014
Primary completionActual
Aug 2016
CompletionActual
Aug 2016
Results first posted
Mar 1, 2023
Last update
Dec 27, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02325154
Responsible party
Sponsor
First posted
Dec 24, 2014
Start date
Dec 2014
Primary completion
Aug 2016
Completion
Aug 2016
Results posted
Mar 1, 2023
Last update
Dec 27, 2024

Study contacts

Sean Garvin, MD
principal investigator · Hospital for Special Surgery, New York

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion